History
The International Serum Industry Association was formed in June 2006 with a specific focus on the Serum Industry. Since that time the scope of the Association has broadened to include all animal derived products used in the multibillion dollar life science and biomedical sectors.The Association does not currently include food applications or human derived materials within its sphere of influence.
Click here to read a description of the ISIA journey to today.
Attendees at the April 2018 Annual Meeting in New Orleans
ISIA Mission
ETHICS
ISIA shall establish, promote and assure compliance with uncompromised standards of excellence and ethics in the business practices of the global animal serum and animal derived products supply industry.
SAFETY AND SAFE USE
Our primary focus will be on safety and safe use of serum and animal derived products through proper origin traceability, and truth in labeling, and appropriate standardization and oversight.
EDUCATION
We will also work to educate stakeholders on the scientific foundation of the safe use of serum and animal derived products.
Planning For Our Future
ISIA continues to implement an extensive Strategic Planning Initiative focused on four key areas.
Standardization
ISIA is working to harmonize technical standards, testing methods, and import/export for the industry.
Education
ISIA is working to proactively educate those involved with our products about our industry, and our Association.
Regulatory
ISIA is working to interpret regulations, participate in the development of new regulations affecting our industry, and strengthen our position as resource and liason with global regulatory agencies.
Traceability
ISIA is working to continually improve, promote, and manage the ISIA Traceability Program. Additionally, ISIA is working to strengthen the Traceability Program in the future by researching the applicability of quantitative methods and new technologies to the Serum industry.
Global Network
ISIA has developed a worldwide network of contacts with regulatory agencies, other associations and interested parties. We continue to proactively develop these resources for our membership.
BOARD OF DIRECTORS | Click on each name to see Board Member Bio | |
| JENNY MURRAY | Board Chair | Life Science Group |
| STEPHEN JUDD | Board Vice Chair | Axenia BioLogix |
| JIM CREAN | Director | Gibco-Thermo Fisher Scientific |
| BOB CURRY | Director | Corning Life Sciences/VACCA |
| BRIAN DOUGLASS | Director | GE Healthcare |
| NICOLE GREEN | Director | Central Biomedia |
| BRIAN LEWIS | Director | VWR |
| ELIZABETH MEIXNER | Director | Moregate |
| GUILHERME ESTEVES | Director | River City Brazil |
| RICK PANICCIA | Director | Atlas Biologicals |
| GARETH WILLIAMS | Director | TCS Biosciences Ltd. |
OFFICERS | ||
| ROSEMARY VERSTEEGEN | CEO* | ISIA |
| STEPHEN JUDD | CFO* | ISIA |
| JOCK ELLIOTT | Secretary* | ISIA |
| non-voting* | ||
| STAFF | ||
| STEVE DOELGER | Operations Manager* | ISIA |
| JULIA HOFFMANN | Exec. Asst. to the CEO* | ISIA |
